Navigation Links
Champions Biotechnology Reports Fiscal 2010 First Quarter Financial Results
Date:9/14/2009

rug candidate. The soluble form was developed by Do-Coop which enables SG410 to advance to Tumorgraft testing.
  • The Company conducted its first Personalized Oncology Panel(TM) in Israel and built infrastructure to grow the business there.
  • The Company launched its Personalizedcancertreatment.com website that provides information and access to the Company's personalized treatment program.

    • Furthermore, as previously announced, since the end of the July 31, 2009 quarter, the Company entered into a major collaboration agreement with PinnacleCare, the world's leading private health advisory. This partnership will enable Champions to educate many more physicians regarding the Company's services and assist many more individuals with cutting edge research to personalize their cancer treatment.

    For more information regarding Champions Biotechnology's business and recent news, please visit www.championsbiotechnology.com. To learn more about personalized cancer treatment, please visit www.personalizedcancertreatment.com.

    About Champions Biotechnology, Inc.

    Champions Biotechnology, Inc. is engaged in the development of advanced preclinical platforms and tumor specific data to enhance and accelerate the value of oncology drugs. The Company's Preclinical Platform is a novel approach based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting engraftments (Biomerk Tumorgrafts(TM)) in a manner that preserves the biological characteristics of the original human tumor. Early studies suggest
    '/>"/>

    SOURCE Champions Biotechnology, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5

    Related biology technology :

    1. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
    2. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
    3. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
    4. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
    5. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
    6. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
    7. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
    8. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
    9. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
    10. Champions Biotechnology Reports Fiscal 2009 Full-Year Financial Results
    11. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
    (Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
    (Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
    (Date:12/1/2009)Dr. Kerry Solomon announced that he has joined Carolina Eyecare Physicians and has launched his redesigned website at www.DrKerrySolomon.com , which was developed by Medical Consulting Group. Dr. So
    Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
    ...is. - Building the Merge Healthcare of tomorrow...ains, will mean offshoring 150 jobs to a "more cos...duce 28 percent of the financially troubled medica...ed States, Canada, and Japan to regain the competi...anization initiative euphemistically labeled right...
    ...is. - TeraMedica , a medical informatics company...uct line, the VisLite Information Manager , an ...erability between clinical departments. , ,The pro...al medical images and connects them to existing el... also uses open standards in managing and storing ...
    ...is. - Quick quiz: Which Wisconsin institutions sp...fe sciences? , ,Naming No. 1 is relatively easy: t...) is perennially among the top academic R&D center... Medical College of Wisconsin ($139 million), whi...ch centers. Next up is the University of Wisconsi...
    Other Biology Technology:Merge offshoring jobs to "more cost-effective" workforce 2Merge offshoring jobs to "more cost-effective" workforce 3Marshfield Clinic and UW combine to speed tech growth 2Marshfield Clinic and UW combine to speed tech growth 3Marshfield Clinic and UW combine to speed tech growth 4
    (Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
    (Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
    (Date:12/2/2009)PHILADELPHIA Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient,s future risk of death, according to published studies. Now, results of a ne
    Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Head and neck cancer survivors who use alcohol and cigarettes have increased death risk 2Smart Balance Announces 2009 Second Quarter Results 53838 1Smart Balance Announces 2009 Second Quarter Results 53838 2Smart Balance Announces 2009 Second Quarter Results 53838 3Smart Balance Announces 2009 Second Quarter Results 53838 4Smart Balance Announces 2009 Second Quarter Results 53838 5Smart Balance Announces 2009 Second Quarter Results 53838 6Smart Balance Announces 2009 Second Quarter Results 53838 7Smart Balance Announces 2009 Second Quarter Results 53838 8Smart Balance Announces 2009 Second Quarter Results 53838 9Smart Balance Announces 2009 Second Quarter Results 53838 10Oncothyreon announces webcast of second quarter 2009 financial results conference call 13414 1U S Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 53832 1U S Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 53832 2U S Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 53832 3
    ... Illinois at Chicago have identified an elusive su... humans and the much-studied laboratory nematode C...on muscle function. , The neurotransmitter acetylc...at the nematode,s neuromuscular junctions, causing...e subunit composition only of the levamisole-sensi...
    ...e molecule in the cell can serve as an advanced to...y may use a technique in which non-invasive magnet...olecule. The results of this research, conducted b...Biological Regulation Department, were published i...er with Dr. Batya Cohen of the Institute,s Molecul...
    ...ed at Johns Hopkins show that stem cell therapy ca...yocardial infarction, in pigs. In just two months,...ow and injected into the animal,s damaged heart re...uscle by 50 percent to 75 percent. , The Hopkins f...entific Sessions of the American Heart Association...
    Other Biology News:Small worm yields big clue on muscle receptor action 2Novel live reporting system to track cells 2Stem cell therapy successfully treats heart attack in animals 2
    PPase-2A from Promega
    Mouse Anti-Salmonella typhimurium Monoclonal Antibody, Unconjugated, Clone 8C11C from ABR-Affinity BioReagents
    AgarACE Enzyme from Promega
    TNT® T7 Quick Coupled Transcription/Translation System from Promega
    Biology Products: